This inventor holds 4 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Indiana University, Gachon University of Industry-Academic Cooperation Foundation, Gachon University of Industry—academic Cooperation. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 809 
1 out of 70 
1 out of 1 Years Active: 2019-2025
Title: Seung-Yong Seo: Innovator in Pharmaceutical Compounds
Introduction
Seung-Yong Seo is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues such as obesity and diabetes. With a total of 4 patents to his name, Seo's work is recognized for its potential impact on medical treatments.
Latest Patents
Seo's latest patents include a novel 4-carbonylamino-4-phenylpyrimidine compound or a pharmaceutically acceptable salt thereof. This invention is particularly noteworthy as it exhibits GDH activity, making it effective for the prevention or treatment of obesity, diabetes, or fatty liver. Another significant patent involves ferrochelatase inhibitors and methods of use, which relate to treating patients with these inhibitors or their derivatives.
Career Highlights
Throughout his career, Seung-Yong Seo has worked with prestigious institutions such as Indiana University and Gachon University of Industry-Academic Cooperation Foundation. His research and innovations have contributed to advancements in pharmaceutical sciences, showcasing his dedication to improving health outcomes.
Collaborations
Seo has collaborated with notable individuals in his field, including Timothy William Corson and Bit Lee. These partnerships have likely enhanced the scope and impact of his research endeavors.
Conclusion
Seung-Yong Seo's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work continues to pave the way for new treatments that can significantly improve patient health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile